Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/137101
Current applications of nanoemulsions in cancer therapeutics.
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Nanoemulsions are pharmaceutical formulations composed of particles within a nanometer range. They possess the capacity to encapsulate drugs that are poorly water soluble due to their hydrophobic core nature. Additionally, they are also composed of safe gradient excipients, which makes them a stable and safe option to deliver drugs. Cancer therapy has been an issue for several decades. Drugs developed to treat this disease are not always successful or end up failing, mainly due to low solubility, multidrug resistance (MDR), and unspecific toxicity. Nanoemulsions might be the solution to achieve e cient and safe tumor treatment. These formulations not only solve water-solubility problems but also provide specific targeting to cancer cells and might even be designed to overcome MDR. Nanoemulsions can be modified using ligands of di erent natures to target components present in tumor cells surface or to escape MDR mechanisms. Multifunctional nanoemulsions are being studied by a wide variety of researchers in di erent research areas mainly for the treatment of di erent types of cancer. All of these studies demonstrate that nanoemulsions are e ciently taken by the tumoral cells, reduce tumor growth, eliminate toxicity to healthy cells, and decrease migration of cancer cells to other organs.
Matèries (anglès)
Citació
Citació
SÁNCHEZ-LÓPEZ, E. (elena), GUERRA, Mariana, DIAS-FERREIRA, João, LÓPEZ-MACHADO, Ana, ETTCHETO ARRIOLA, Miren, CANO FERNÁNDEZ, Amanda, ESPINA GARCÍA, Marta, CAMINS ESPUNY, Antoni, GARCÍA, Maria luisa, SOUTO, Eliana b.. Current applications of nanoemulsions in cancer therapeutics.. _Nanomaterials_. 2019. Vol. 9, núm. 821. [consulta: 31 de gener de 2026]. ISSN: 2079-4991. [Disponible a: https://hdl.handle.net/2445/137101]